SOVALDI

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1379012
                    [Title] => New once-a-day pill for hepatitis C wins FDA OK
                    [Summary] => 
Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.

                    [DatePublished] => 2014-10-11 03:03:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1265295
                    [Title] => FDA approves breakthrough hepatitis C drug
                    [Summary] => 
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

                    [DatePublished] => 2013-12-07 07:32:52
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img4.imageshack.us/img4/181/l7wd.jpg
                )

        )

)

abtest

New once-a-day pill for hepatitis C wins FDA OK

By Matthew Perrone | October 11, 2014 - 3:03am

Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.

Health And Family

FDA approves breakthrough hepatitis C drug

By Matthew Perrone | December 7, 2013 - 7:32am

Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to...

Health And Family